Royal Bank of Canada Increases Stake in BlackRock Capital Allocation Term Trust $BCAT

Key Points

• Royal Bank of Canada increased its BCAT stake by 50.2% in the first quarter, adding 190,604 shares to own 570,035 shares valued at approximately $8.1 million, or 0.54% of the trust.
• Institutional ownership stands at 36.12%, with several other investors also expanding their positions, including Global Retirement Partners and Brown Brothers Harriman.
• BCAT recently traded at $16.08, near its 12-month high of $16.18, and announced a monthly dividend of $0.2542, representing an approximately 19.0% annualized yield.

Royal Bank of Canada boosted its stake in BlackRock Capital Allocation Term Trust (NYSE:BCAT - Free Report) by 50.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 570,035 shares of the company's stock after buying an additional 190,604 shares during the period. Royal Bank of Canada owned 0.54% of BlackRock Capital Allocation Term Trust worth $8,055,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Geneos Wealth Management Inc. grew its holdings in shares of BlackRock Capital Allocation Term Trust by 341.7% during the 2nd quarter. Geneos Wealth Management Inc. now owns 2,045 shares of the company's stock worth $31,000 after acquiring an additional 1,582 shares during the period. N.E.W. Advisory Services LLC boosted its position in shares of BlackRock Capital Allocation Term Trust by 100.0% during the fourth quarter. N.E.W. Advisory Services LLC now owns 2,400 shares of the company's stock valued at $34,000 after purchasing an additional 1,200 shares in the last quarter. Parallel Advisors LLC bought a new stake in shares of BlackRock Capital Allocation Term Trust during the third quarter valued at approximately $47,000. Brown Brothers Harriman & Co. grew its stake in BlackRock Capital Allocation Term Trust by 450.0% in the third quarter. Brown Brothers Harriman & Co. now owns 5,500 shares of the company's stock worth $81,000 after purchasing an additional 4,500 shares during the period. Finally, Global Retirement Partners LLC grew its stake in BlackRock Capital Allocation Term Trust by 1,856.5% in the fourth quarter. Global Retirement Partners LLC now owns 8,687 shares of the company's stock worth $123,000 after purchasing an additional 8,243 shares during the period. 36.12% of the stock is owned by institutional investors.

BlackRock Capital Allocation Term Trust Trading Up 0.2%

BCAT opened at $16.08 on Tuesday. The stock has a fifty day simple moving average of $15.76 and a two-hundred day simple moving average of $15.24. BlackRock Capital Allocation Term Trust has a 12-month low of $13.73 and a 12-month high of $16.18.

BlackRock Capital Allocation Term Trust Announces Dividend

The firm also recently announced a monthly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Tuesday, September 15th will be given a $0.2542 dividend. The ex-dividend date of this dividend is Tuesday, September 15th. This represents a c) dividend on an annualized basis and a dividend yield of 19.0%.

About BlackRock Capital Allocation Term Trust

BlackRock Capital Allocation Term Trust NYSE: BCAT is a closed-end, diversified management investment company organized as a term trust. The fund's primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.

BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source